The Heterogeneous Prognosis of Patients with Myelodysplastic Syndrome (MDS) and Chromosome 5 Abnormalities: How Does It Relate to the Original Lenalidomide Experience in MDS?

被引：0
|
作者：
Kantarjian, Hagop M. [1 ]
O'Brien, Susan [2 ]
Ravandi, Farhad [2 ]
Borthakur, Gautam [2 ]
Faderl, Stefan [2 ]
Bueso-Ramos, Carlos [2 ]
Abruzzo, Lynne [2 ]
Pierce, Sherry [2 ]
Shan, Jianqin [2 ]
Issa, Jean-Pierre [2 ]
Garcia-Manero, Guillermo [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：580 / 580
页数：1
相关论文
共 50 条
  • [1] The Heterogeneous Prognosis of Patients With Myelodysplastic Syndrome and Chromosome 5 Abnormalities How Does It Relate to the Original Lenalidomide Experience in MDS?
    Kantarjian, Hagop
    O'Brien, Susan
    Ravandi, Farhad
    Borthakur, Gautam
    Faderl, Stefan
    Bueso-Ramos, Carlos
    Abruzzo, Lynne
    Pierce, Sherry
    Shan, Jianqin
    Issa, Jean-Pierre
    Garcia-Manero, Guillermo
    CANCER, 2009, 115 (22) : 5202 - 5209
  • [2] CHROMOSOME-ABNORMALITIES AND KARYOTYPIC EVOLUTION IN 83 PATIENTS WITH MYELODYSPLASTIC SYNDROME PREDICTIVE VALUE FOR THE PROGNOSIS OF MDS
    ABE, T
    HORIIKE, S
    YASHIGE, H
    YOKOTA, S
    TANIWAKI, M
    MISAWA, S
    TAKINO, T
    BLUT, 1988, 56 (06): : C9 - C9
  • [3] Lenalidomide effects on NK function in patients with myelodysplastic syndrome (MDS).
    Epling-Burnette, PK
    Bai, FQ
    Painter, JS
    Djeu, JY
    List, AF
    BLOOD, 2005, 106 (11) : 959A - 960A
  • [4] Efficacy of lenalidomide for treatment of anemia in secondary myelodysplastic syndrome (MDS) with chromosome 5q deletion
    Mintzer, David Michael
    Billet, Shira N.
    BLOOD, 2007, 110 (11) : 226B - 226B
  • [5] LENALIDOMIDE TREATMENT IN 20 PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS). MULTICENTER REGISTRY
    Arrizabalaga, B.
    Del Orbe, R.
    Zamora, M.
    Ardanaz, M.
    Arguinano, J.
    Sirvent, M.
    Atucha, L.
    Atucha, J.
    Insunza, A.
    Montes, C.
    Campeny, A.
    HAEMATOLOGICA, 2013, 98 : 585 - 585
  • [6] Translocations involving chromosome 5q found in patients with myelodysplastic syndrome (MDS)
    Michalova, K
    Zemanova, Z
    Brezinova, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1254 - 1254
  • [7] Outcomes of Myelodysplastic Syndromes (MDS) Patients with Chromosome 17 Abnormalities: A Report on Behalf of the MDS Clinical Research Consortium (MDSCRC)
    Komrokji, Rami S.
    Al Ali, Najla
    Barnard, John
    Steensma, David P.
    DeZern, Amy E.
    Roboz, Gail J.
    Sallman, David A.
    Padron, Eric
    Nazha, Aziz
    List, Alan F.
    Garcia-Manero, Guillermo
    Sekeres, Mikkael A.
    BLOOD, 2017, 130
  • [8] Complex rearrangements of chromosome 5 with interstitial deletion of long arms in patients with myelodysplastic syndrome (MDS)
    Michalová, K
    Zemanová, Z
    Brezinová, J
    CYTOGENETICS AND CELL GENETICS, 1998, 81 (02): : 153 - 153
  • [9] Results of phase II clinical study of lenalidomide in Japanese patients with myelodysplastic syndrome (MDS)
    Harada, H.
    Watanabe, M.
    Suzuki, K.
    Yanagita, S.
    Suzuki, T.
    Yoshida, Y.
    Kimura, A.
    Tsudo, M.
    Takatoku, M.
    Ozawa, K.
    LEUKEMIA RESEARCH, 2009, 33 : S123 - S123
  • [10] Involvement of long arms of chromosome 5 in complex translocations in myelodysplastic syndrome (MDS)
    Michalova, K
    Zemanova, Z
    Brezinova, J
    Cermak, J
    Siskova, M
    Chudoba, I
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 80 - 80
12345